Desiderata for Major Eligibility Criteria in Breast Cancer Clinical Trials

Area of Science:

• Clinical Research Methodology
• Oncology
• Health Services Research

Background:

• Major eligibility criteria are commonly used to improve patient screening efficiency in clinical studies, but this practice remains largely unexamined.
• Optimizing patient screening is crucial for maximizing recruitment rates in clinical trials, particularly in complex fields like breast cancer research.

Purpose of the Study:

• To derive the desiderata for major eligibility criteria in breast cancer clinical trials.
• To understand the current prescreening process and identify opportunities for optimization to enhance patient recruitment.

Main Methods:

• A mixed-methods approach was employed, including a think-aloud protocol with clinical researchers and a focus group session.
• Grounded theory was used to analyze transcribed interviews and focus group discussions to identify user rationale and desiderata.
• A survey was conducted to evaluate the discovered desiderata.

Main Results:

• The study identified specific user rationales and desiderata guiding the application of major eligibility criteria in breast cancer clinical trials.
• Insights into the current prescreening process were gained, highlighting areas for potential improvement in efficiency and recruitment.

Conclusions:

• The findings provide a foundation for developing evidence-based guidelines for utilizing major eligibility criteria to improve breast cancer clinical trial efficiency.
• Optimizing the use of eligibility criteria can lead to enhanced patient recruitment and streamline the clinical trial process.